Targeting the post-irradiation tumor microenvironment in glioblastoma via inhibition of CXCL12

Abstract: Radiotherapy is a mainstay in glioblastoma therapy as it not only directly targets tumor cells but also depletes the tumor microvasculature. The resulting intra-tumoral hypoxia initiates a chain of events that ultimately leads to re-vascularization, immunosuppression and, ultimately, tumor-regrowth. The key component of this cascade is overexpression of the CXC-motive chemokine ligand 12 (CXCL12), formerly known as stromal-cell derived factor 1 (SDF-1). We here review the role of CXCL12 in recruitment of pro-vasculogenic and immunosuppressive cells and give an overview on future and current drugs that target this axis

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch
Notes
issn: 2072-6694

Keyword
Glioblastom
Strahlentherapie
Chemokin CXCL12

Event
Veröffentlichung
(where)
Freiburg
(who)
Universität
(when)
2019

DOI
10.3390/cancers11030272
URN
urn:nbn:de:bsz:25-freidok-1492958
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:49 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Time of origin

  • 2019

Other Objects (12)